HIS
RCKT icon

Harvest Investment Services’s Rocket Pharmaceuticals RCKT Stock Holding History

Harvest Investment Services’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-26,684
Closed -$457K – 185
2023
Q1 		$457K Buy
+26,684
New +$522K 0.35% 71

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Harvest Investment Services's RCKT Position: Q2 2023 in Review

Harvest Investment Services sold out of Rocket Pharmaceuticals (RCKT) in Q2 2023, closing a stake of 26,684 shares — an estimated $457K sold.

Harvest Investment Services first reported a position in RCKT in Q1 2023 and held it in 1 quarter. The position peaked at $457K in Q1 2023. 164 funds tracked by Wall St. Rank hold RCKT as of Q2 2023.

  • Harvest Investment Services reported no remaining Rocket Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Harvest Investment Services sold 26,684 Rocket Pharmaceuticals shares in Q2 2023, an estimated $457K.
  • Harvest Investment Services first reported a position in Rocket Pharmaceuticals in Q1 2023 and held it in 1 quarter.
  • Harvest Investment Services's Rocket Pharmaceuticals position peaked at $457K in Q1 2023.
  • 164 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2023.

Based on Harvest Investment Services's 13F filing for Q2 2023, filed 11 Aug 2023.